1. 以HSP-27为靶点的反义核甘正处于第二期临床试验中。
Phase II trials with an antisense oligonucleotide against HSP-27 in CRPC are underway.

来自互联网

2. 方法应用三对具有特异性的核普引物,进行多重PCR扩增。
Method three pairs of oligonucleotide primer were used in triplex-PCR.

来自互联网

3. 方法应用三对具有特异性的核普引物,进行多重PCR扩增。
Method three pairs of oligonucleotide primer were used in triplex-PCR.

来自互联网